Impact of viral sensitizer-enhanced oncolytic virus immunotherapy on the anti-tumor immune response

被引：0
|
作者：
Alluqmani, Nouf N. [1 ,2 ]
Bergeron, Anabel [1 ,2 ]
Chen, Andrew [2 ]
Khan, Sarwat [2 ]
Forbes, Nicole [2 ]
Arulanandam, Rozanne [2 ]
Souza, Christiano [2 ]
Crans, Debbi C. [3 ,4 ]
Diallo, Jean-Simon [1 ,2 ]
机构：
[1] Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON, Canada
[2] Ottawa Hosp Res Inst, Ctr Innovat Canc Res, Ottawa, ON, Canada
[3] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA
[4] Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA
来源：
JOURNAL OF IMMUNOLOGY | 2020年 / 204卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
169.21
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Oncolytic virus elicits anti-tumor immune response comparing to chemotherapy drugs
    Kasuya, Hideki
    Takeda, Shin
    Watanabe, Izuru
    Nomura, Naohiro
    Fujii, Tsutomu
    Nakao, Akimasa
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [2] Evolution of anti-viral and anti-tumor immunity in tumors in response to oncolytic virus therapy
    Lyudovyk, Olga
    Burman, Bharat
    Ceglia, Nicholas
    Greenbaum, Benjamin
    Elhanati, Yuval
    Zamarin, Dmitriy
    [J]. CANCER RESEARCH, 2024, 84 (07)
  • [3] Gentically engineered oncolytic vesicular stomatitis virus to stimulate anti-tumor immune response
    Leveille, Simon
    Hiscott, John
    [J]. CYTOKINE, 2008, 43 (03) : 325 - 325
  • [4] DAI-armed double deleted oncolytic vaccinia virus displays enhanced anti-tumor activity by eliciting a more robust anti-tumor immune response
    Capasso, C.
    Hirvinen, M.
    Guse, K.
    Ahonen, M.
    Karli, E.
    Greco, D.
    Vaha-Koskela, M.
    Hemminki, A.
    Cerullo, V.
    [J]. HUMAN GENE THERAPY, 2013, 24 (12) : A56 - A56
  • [5] DAI-Armed Double Deleted Oncolytic Vaccinia Virus Displays Enhanced Anti-Tumor Activity by Eliciting a More Robust Anti-Tumor Immune Response
    Hirvinen, Mari
    Guse, Kilian
    Ahonen, Marko
    Karli, Eerika
    Greco, Dario
    Vaha-Koskela, Markus
    Hemminki, Akseli
    Cerullo, Vincenzo
    [J]. MOLECULAR THERAPY, 2013, 21 : S193 - S194
  • [6] Quantifying the Anti-tumor Immune Response in Patients Receiving Immunotherapy
    Caushi, Justina X.
    Smith, Kellie N.
    [J]. DISCOVERY MEDICINE, 2017, 24 (130) : 59 - 68
  • [7] Multifunctional hybrid oncolytic virus-mimicking nanoparticles for targeted induce of tumor-specific pyroptosis and enhanced anti-tumor immune response in melanoma
    Ma, Fanshu
    Cao, Yi
    Yan, Jincong
    Lu, Zhongzhong
    Sun, Lina
    Hussain, Zahid
    Wang, Zheng
    Wang, Li
    Pei, Renjun
    [J]. NANO TODAY, 2024, 54
  • [8] Oncolytic Vaccinia Virus Armed with GM-CSF: Studies on Safety, Efficacy, Anti-Viral and Anti-Tumor Immune Response in Immunocompetent and Immunodeficient Rodents
    Parviainen, Suvi T.
    Ahonen, Marko
    Diaconu, Iulia
    Pesonen, Sari
    Hemminki, Akseli
    Cerullo, Vincenzo
    [J]. MOLECULAR THERAPY, 2012, 20 : S273 - S273
  • [9] IN SITU VACCINATION WITH ONCOLYTIC VESICULAR STOMATITIS VIRUS IMPROVES ANTI-TUMOR IMMUNE RESPONSE AND OUTCOME IN BLADDER CANCER
    Rangsitratkul, Coby
    Lawson, Christine
    Tai, Lee-Hwa
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A357 - A357
  • [10] Disentangling Anti-Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab
    Sancho-Araiz, Aymara
    Parra-Guillen, Zinnia P.
    Troconiz, Inaki F.
    Freshwater, Tomoko
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024,
12345